Nucleoside analogs in combination therapy of herpes simplex...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/52 (2006.01) A61K 31/56 (2006.01) A61K 31/675 (2006.01) A61K 38/13 (2006.01)

Patent

CA 2244268

A pharmaceutical product comprising a nucleoside analogue active against herpes simplex virus, such as acyclovir/valaciclovir or penciclovir/famciclovir, and an immunosuppressant, as a combined preparation for simultaneous, separate or sequential use in the treatment and/or prevention of herpes simplex virus infections.

Cette invention concerne un produit pharmaceutique qui comprend un analogue de nucléoside agissant contre le virus de l'herpès simplex, tel que de l'acyclovir/valaciclovir ou du penciclovir/famciclovir, ainsi qu'un immunosuppresseur. Ce produit est utilisé sous forme d'une préparation combinée et de manière simultanée, séparée ou séquentielle dans le traitement et/ou la prévention d'infections dues au virus de l'herpès simplex.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Nucleoside analogs in combination therapy of herpes simplex... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nucleoside analogs in combination therapy of herpes simplex..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleoside analogs in combination therapy of herpes simplex... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1765145

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.